Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 Patients

Gugel, Isabel; Kluwe, Lan; Zipfel, Julian; Teuber, Christian; Tatagiba, Marcos; Mautner, Victor-Felix; Schuhmann, Martin Ulrich; Grimm, Florian

dc.contributor.author	Gugel, Isabel
dc.contributor.author	Zipfel, Julian
dc.contributor.author	Teuber, Christian
dc.contributor.author	Tatagiba, Marcos
dc.contributor.author	Mautner, Victor Felix
dc.contributor.author	Schuhmann, Martin Ulrich
dc.contributor.author	Grimm, Florian Marius
dc.date.accessioned	2020-07-08T14:12:50Z
dc.date.available	2020-07-08T14:12:50Z
dc.date.issued	2019
dc.identifier.issn	2072-6694
dc.identifier.uri	http://hdl.handle.net/10900/102426
dc.language.iso	en	de_DE
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/cancers11121862	de_DE
dc.subject.ddc	610	de_DE
dc.title	Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 Patients	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200409032300_00191
utue.personen.roh	Gugel, Isabel
utue.personen.roh	Kluwe, Lan
utue.personen.roh	Zipfel, Julian
utue.personen.roh	Teuber, Christian
utue.personen.roh	Tatagiba, Marcos
utue.personen.roh	Mautner, Victor-Felix
utue.personen.roh	Schuhmann, Martin Ulrich
utue.personen.roh	Grimm, Florian
dcterms.isPartOf.ZSTitelID	Cancers	de_DE
dcterms.isPartOf.ZS-Issue	Article 1862	de_DE
dcterms.isPartOf.ZS-Volume	11	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE